GeneReach Biotechnology Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
GeneReach Biotechnology Corp Changes General Manager
GeneReach Biotechnology Corp announced the change of General Manager from Liu Zhengzhong to Zhang Xiaofen, effective February 20, 2013.
Latest Key Developments in Pharmaceuticals
- Chembio Diagnostics Inc appoints president and CEO
- Theravance Inc and GlaxoSmithKline plc announces positive results from studies comparing ANORO ELLIPTA With SERETIDE DISKUS and ADVAIR DISKUS in Patients With COPD
- Theravance Inc and GlaxoSmithKline Plc announces positive results from studies comparing ANORO ELLIPTA With SERETIDE DISKUS and ADVAIR DISKUS in Patients With COPD
- Cipher Pharmaceuticals Inc announces Larry Andrews will be stepping down as President and Chief Executive Officer
- Share this
- Digg this